ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: FLARE

ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

Susan Bernstein  |  March 1, 2013

Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment

Filed under:Meeting Reports Tagged with:ACR/ARHP Annual MeetingInfectionRheumatic DiseaseTreatmentTuberculosis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Drug Updates Tagged with:ApprovalsDrugsFDAPipeline

Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

William P. Docken MD  |  March 1, 2013

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

Filed under:ConditionsSoft Tissue Pain Tagged with:Clinicalinflammationrheumatology

ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus

Susan Bernstein  |  February 1, 2013

Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE

Filed under:ConditionsMeeting ReportsResearch RheumSystemic Lupus Erythematosus Tagged with:comorbiditiesLupusResearchSLETreatment

ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront

Mary Beth Nierengarten  |  January 1, 2013

Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights

Filed under:ConditionsMeeting ReportsPsoriatic ArthritisRheumatoid Arthritis Tagged with:ACR/ARHP Annual Meetingpsoriatic arthritisRA flaresRheumatoid arthritis

Depression in Rheumatoid Arthritis

Perry M. Nicassio, PhD, and Myra Irani, MA  |  November 1, 2012

Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

Filed under:ConditionsRheumatoid Arthritis Tagged with:Depressionpatient carepsychological disorderRheumatoid arthritisrheumatologistTreatment

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2012

Information on new approvals and medication safety rheumatologists need to know

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:Ankylosing SpondylitisBiologicsBiosimilarsdrugFDAinfliximabJAK inhibitorsjanus kinaseMethotrexatePipelinePolymyalgia Rheumaticaprednisonepsoriatic arthritisRheumatoid arthritisSafetyTofacitinib

Rheumatologists Seek Public Vote for Research Grant Award

Michael O’Neal  |  October 17, 2012

Brigham and Women’s docs compete for BRIght Futures Prize for personalized medicine research

Filed under:AwardsResearch Rheum Tagged with:GrantsResearchRheumatoid arthritis

Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?

Reeti K. Joshi, MD, Richa Gupta, MD, Hyon Ju Park, MD, Christine Pham, MD, and Leslie Kahl, MD  |  October 1, 2012

Rheumatologists face the emerging picture of cocaine and levamisole-associated vasculopathy in clinical practice

Filed under:ConditionsVasculitis Tagged with:ANA titerANCA-Associated Vasculitispatient carerheumatologistVasculitisvasculopathy

How Microbes, Mycobacteria, and Metastases May Alter the Way We Look at Rheumatic Diseases

Simon M. Helfgott, MD  |  October 1, 2012

Studying the relationships between microbes and their hosts, the role for Bacille Calmette Guerin (BCG) as a vaccine for Type I diabetes, and emotional stress and bone metastases

Filed under:Axial SpondyloarthritisConditionsOpinionRheumatoid ArthritisRheuminationsSpeak Out RheumSystemic Lupus Erythematosus Tagged with:Cancergut microbiomeHelfgottLupusmicrobeMicrobiomepatient carevaccine

  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 70
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences